420
Views
0
CrossRef citations to date
0
Altmetric
Methods in Addiction Research

Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products

ORCID Icon, ORCID Icon, , ORCID Icon, , , , & show all
Pages 733-745 | Received 20 Feb 2023, Accepted 06 Aug 2023, Published online: 29 Sep 2023

References

  • Borodovsky JT, Crosier BS, Lee DC, Sargent JD, Budney AJ. Smoking, vaping, eating: is legalization impacting the way people use cannabis? Int J Drug Policy. 2016;36:141–47. doi:10.1016/j.drugpo.2016.02.022.
  • Spindle TR, Bonn-Miller MO, Vandrey R. Changing landscape of cannabis: novel products, formulations, and methods of administration. Curr Opin Psychol. 2019;30:98–102. doi:10.1016/j.copsyc.2019.04.002.
  • Lee DC, Schlienz NJ, Peters EN, Dworkin RH, Turk DC, Strain EC, Vandrey R. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug Alcohol Depend. 2019;194:500–17. doi:10.1016/j.drugalcdep.2018.10.020.
  • Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D’Souza DC, Dworkin RH, Gray KM, Hasin DS, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: a review and research agenda. Drug Alcohol Depend. 2020;212:107993.
  • Temple EC, Brown RF, Hine DW. The ‘grass ceiling’: limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction. 2011;106:238–44. doi:10.1111/j.1360-0443.2010.03139.x.
  • Callaghan RC, Sanches M, Kish SJ. Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. Drug Alcohol Depend. 2020;217:108271. doi:10.1016/j.drugalcdep.2020.108271.
  • Asbridge M, Duff C, Marsh DC, Erickson PG. Problems with the identification of ‘problematic’ cannabis use: examining the issues of frequency, quantity, and drug use environment. Eur Addict Res. 2014;20:254–67. doi:10.1159/000360697.
  • Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: evidence from a clinical trial. Drug Alcohol Depend. 2018;182:1–7. doi:10.1016/j.drugalcdep.2017.09.035.
  • Greenfield TK, Rogers JD. Who drinks most of the alcohol in the US? The policy implications. J Stud Alcohol. 1999;60:78–89. doi:10.15288/jsa.1999.60.78.
  • Dawson DA. Methodological issues in measuring alcohol use. Alcohol Res Health. 2003;27:18–29.
  • Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791–800. doi:10.1111/j.1360-0443.1989.tb03059.x.
  • Sikorski C, Leos-Toro C, Hammond D. Cannabis consumption, purchasing and sources among young Canadians: the Cannabis Purchase and Consumption Tool (CPCT). Subst Use Misuse. 2021;56:449–57. doi:10.1080/10826084.2021.1879142.
  • Lorenzetti V, Hindocha C, Petrilli K, Griffiths P, Brown J, Castillo-Carniglia A, Caulkins JP, Englund A, ElSohly MA, Gage SH, et al. The international cannabis toolkit (iCanntoolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction. 2022;117:1510–17. doi:10.1111/add.15702.
  • Freeman TP, Lorenzetti V. ‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration. Addiction. 2020;115:1207–16. doi:10.1111/add.14842.
  • Cannabis Policy Research Workgroup. National advisory council on drug abuse cannabis policy research workgroup report. 2018
  • Gray KM, Watson NL, Christie DK. Challenges in quantifying marijuana use. Am J Addict. 2009;18:178–79. doi:10.1080/10550490902772579.
  • Hindocha C, Freeman TP, Curran HV. Anatomy of a joint: Comparing self-reported and actual dose of cannabis and tobacco in a joint, and how these are influenced by controlled acute administration. Cannabis Cannabinoid Res. 2017;2:217–23. doi:10.1089/can.2017.0024.
  • Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring within-individual cannabis reduction in clinical trials: a review of the methodological challenges. Curr Addict Rep. 2019;6:429–36. doi:10.1007/s40429-019-00290-y.
  • Cooper ZD, Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol. 2008;13:188–95. doi:10.1111/j.1369-1600.2007.00095.x.
  • Curran HV, Hindocha C, Morgan CJ, Shaban N, Das RK, Freeman TP. Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Psychol Med. 2019;49:1574–80. doi:10.1017/S003329171800226X.
  • Borodovsky JT, Budney AJ. Cannabis regulatory science: risk–benefit considerations for mental disorders. Int Rev Psychiatry. 2018;30:183–202. doi:10.1080/09540261.2018.1454406.
  • Caulkins JP, Bao Y, Davenport S, Fahli I, Guo Y, Kinnard K, Najewicz M, Renaud L, Kilmer B. Big data on a big new market: insights from Washington state’s legal cannabis market. Int J Drug Policy. 2018;57:86–94. doi:10.1016/j.drugpo.2018.03.031.
  • Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112:2167–77. doi:10.1111/add.13886.
  • Aston ER, Metrik J, Rosen RK, Swift R, MacKillop J. Refining the marijuana purchase task: using qualitative methods to inform measure development. Exp Clin Psychopharmacol. 2021;29:23–35. doi:10.1037/pha0000355.
  • Borodovsky JT, Sofis MJ, Sherman BJ, Gray KM, Budney AJ. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychol Addict Behav. 2022;36:515–25. doi:10.1037/adb0000817.
  • Mariani JJ, Brooks D, Haney M, Levin FR. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend. 2011;113:249–51. doi:10.1016/j.drugalcdep.2010.08.008.
  • Prince MA, Conner BT, Pearson MR. Quantifying cannabis: a field study of marijuana quantity estimation. Psychol Addict Behav. 2018;32:426–33. doi:10.1037/adb0000370.
  • Cloutier RM, Calhoun BH, Linden-Carmichael AN. Associations of mode of administration on cannabis consumption and subjective intoxication in daily life. Psychol Addict Behav. 2022;36:67–77. doi:10.1037/adb0000726.
  • Callaghan RC, Sanches M, Benny C, Stockwell T, Sherk A, Kish S. Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. Drug Alcohol Depend. 2019;205:107587. doi:10.1016/j.drugalcdep.2019.107587.
  • Hughes JR, Fingar JR, Budney AJ, Naud S, Helzer JE, Callas PW. Marijuana use and intoxication among daily users: an intensive longitudinal study. Addict Behav. 2014;39:1464–70. doi:10.1016/j.addbeh.2014.05.024.
  • Caulkins JP. Recognizing and regulating cannabis as a temptation good. Int J Drug Policy. 2017;42:50–56. doi:10.1016/j.drugpo.2017.01.012.
  • Read JP, Egerton G, Cheesman A, Steers M-L. Classifying risky cannabis involvement in young adults using the Marijuana Consequences Questionnaire (MACQ). Addict Behav. 2022;129:107236. doi:10.1016/j.addbeh.2022.107236.
  • Calhoun BH, Patrick ME, Fairlie AM, Graupensperger S, Walukevich-Dienst K, Lee CM. Hours high as a proxy for marijuana use quantity in intensive longitudinal designs. Drug Alcohol Depend. 2022;240:109628. doi:10.1016/j.drugalcdep.2022.109628.
  • Goodman S, Leos-Toro C, Hammond D. Methods to assess cannabis consumption in population surveys: results of cognitive interviewing. Qual Health Res. 2019;29:1474–82. doi:10.1177/1049732318820523.
  • Bush NJ, Ferguson E, Boissoneault J, Yurasek AM. Reliability of an adaptive marijuana purchase task. Exp Clin Psychopharmacol. 2023;31:491–97. doi:10.1037/pha0000606.
  • Fitzgerald ND, Liu Y, Wang A, Striley CW, Setlow B, Knackstedt L, Cottler LB. Test-retest reliability of a new assessment to detect detailed temporal patterns of polysubstance use. Int J Methods Psychiatr Res. 2022;31:e1912. doi:10.1002/mpr.1912.
  • Budney AJ, Borodovsky JT, Struble CA, Habib MI, Shmulewitz D, Livne O, Aharonovich E, Walsh C, Cuttler C, Hasin DS. Estimating THC consumption from smoked and vaped cannabis products in an online survey of adults who use cannabis. Cannabis cannabinoid Res. In Press. doi:10.1089/can.2022.0238.
  • Borodovsky J, Hasin DS, Shmulewitz D, Walsh C, Livne O, Aharonovich E, Struble CA, Habib MI, Budney A. Typical hits, grams, or joints: evaluating cannabis survey measurement strategies for quantifying consumption. Cannabis cannabinoid Res. In Press. doi:10.1089/can.2022.0237.
  • Dolan SB, Spindle TR, Vandrey R, Johnson MW. Behavioral economic interactions between cannabis and alcohol purchasing: associations with disordered use. Exp Clin Psychopharmacol. 2022;30:159–71. doi:10.1037/pha0000397.
  • Aston ER, Metrik J, MacKillop J. Further validation of a marijuana purchase task. Drug Alcohol Depend. 2015;152:32–38. doi:10.1016/j.drugalcdep.2015.04.025.
  • Strickland JC, Lile JA, Stoops WW. Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand. Behav Process. 2017;140:33–40. doi:10.1016/j.beproc.2017.03.017.
  • Lynch J, Lorenz L, Brueggemeyer JL, Lanzarotta A, Falconer TM, Wilson RA. Simultaneous temperature measurements and aerosol collection during vaping for the analysis of Δ9-tetrahydrocannabinol and vitamin E acetate mixtures in ceramic coil style cartridges. Front Chem. 2021;9. doi:10.3389/fchem.2021.734793.
  • Varlet V, Concha-Lozano N, Berthet A, Plateel G, Favrat B, De Cesare M, Lauer E, Augsburger M, Thomas A, Giroud C. Drug vaping applied to cannabis: is “Cannavaping” a therapeutic alternative to marijuana? Sci Rep. 2016;6:25599. doi:10.1038/srep25599.
  • McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacol (Berl). 2012;220:309–18. doi:10.1007/s00213-011-2480-4.
  • Heishman SJ, Stitzer ML, Yingling JE. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav. 1989;34:173–79. doi:10.1016/0091-3057(89)90369-9.
  • Matthias P, Tashkin DP, Marques-Magallanes JA, Wilkins JN, Simmons MS. Effects of varying marijuana potency on deposition of tar and Δ9-THC in the lung during smoking. Pharmacol Biochem Behav. 1997;58:1145–50. doi:10.1016/S0091-3057(97)00328-6.
  • Wu TC, Tashkin DP, Rose JE, Djahed B. Influence of marijuana potency and amount of cigarette consumed on marijuana smoking pattern. J Psychoact Drugs. 1988;20:43–46. doi:10.1080/02791072.1988.10524370.
  • Borodovsky JT, Marsch LA, Budney AJ. Studying cannabis use behaviors with Facebook and Web surveys: methods and insights. JMIR Public Health Surveill. 2018;4:e48. doi:10.2196/publichealth.9408.
  • Cuttler C, Spradlin A, Ito E. Measuring cannabis consumption: psychometric properties of the daily sessions, frequency, age of onset, and quantity of cannabis use inventory (DFAQ-CU). PLoS One. 2017;12:e0178194. doi:10.1371/journal.pone.0178194.
  • Hädener M, Vieten S, Weinmann W, Mahler H. A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids. Forensic Sci Int. 2019;295:207–12. doi:10.1016/j.forsciint.2018.12.021.
  • Klesges RC, Debon M, Ray JW. Are self-reports of smoking rate biased? Evidence from the second National Health and nutrition examination survey. J Clin Epidemiol. 1995;48:1225–33. doi:10.1016/0895-4356(95)00020-5.
  • Borodovsky JT. Generalizability and representativeness: considerations for internet-based research on substance use behaviors. Exp Clin Psychopharmacol. 2022;30:466–77. doi:10.1037/pha0000581.
  • Borodovsky JT, Sofis MJ, Grucza RA, Budney AJ. The importance of psychology for shaping legal cannabis regulation. Exp Clin Psychopharmacol. 2021;29:99–115. doi:10.1037/pha0000362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.